SCHEMBL4309954

SCHEMBL4309954

Cc1ccccc1-c1cccc(CN2CCC3(CC2C)CN(C)S(=O)(=O)N3c2cccc(F)c2)c1

nearest known ligand 0.70

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
BACE1 P56817 20/20 0.70

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1171281 1.00 BACE1 (0.70) BACE1
SCHEMBL1429566 0.89 BACE1 (0.76) BACE1
SCHEMBL1170699 0.89 BACE1 (0.76) BACE1
SCHEMBL1170494 0.88 BACE1 (0.66) BACE1
SCHEMBL2555837 0.87 BACE1 (0.65) BACE1
SCHEMBL4321083 0.86 BACE1 (0.84) BACE1
SCHEMBL1170658 0.86 BACE1 (0.84) BACE1
SCHEMBL1171014 0.85 BACE1 (0.77) BACE1
SCHEMBL1429888 0.85 BACE1 (0.77) BACE1
SCHEMBL1429884 0.83 BACE1 (0.77) BACE1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009136350-A1 NOVEL CLASS OF SPIRO PIPERIDINES FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES PFIZER INC. (US) 2009-11-12 WO claimed
WO-2009136350-A1 NOVEL CLASS OF SPIRO PIPERIDINES FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES PFIZER INC. (US) 2009-11-12 WO disclosed